Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
1.570
+0.040 (2.61%)
At close: Nov 6, 2026, 4:00 PM EST
1.569
-0.001 (-0.08%)
After-hours: Nov 6, 2026, 7:54 PM EST

Lipocine Revenue

Lipocine had revenue of $2.29M in the quarter ending September 30, 2026, with 1,898.77% growth. This brings the company's total for the last twelve months to $3.74M, down -13.37% year-over-year. In the year 2025, Lipocine had annual revenue of $1.98M, down -82.35%. That makes Lipocine the 40,881st largest company in the world by revenue and 5,473rd in the United States.

Revenue (ttm)
$3.74M
Revenue Growth
-13.37%
P/S Ratio
3.46
Revenue / Employee
$267,497
Employees
14
Market Cap
12.94M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.98M-9.22M-82.35%
Dec 31, 202411.20M8.13M264.67%
Dec 31, 20233.07M2.57M514.16%
Dec 31, 2022500.00K--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019164.99K-263.04K-61.45%
Dec 31, 2018428.03K--
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 20127.71M--
Dec 31, 2011---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.